XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.3
Note 17 - Earnings Per Share
3 Months Ended
Sep. 30, 2025
Notes to Financial Statements  
Earnings Per Share [Text Block]

Note 17 - Earnings Per Share

 

Basic net income or loss per share is calculated by dividing net income or loss available to common stockholders by the basic weighted-average number of common shares outstanding for the respective period. Diluted net income or loss per share is calculated by dividing adjusted net income or loss by the diluted weighted-average number of common shares outstanding, which includes the effect of potentially dilutive securities. Potentially dilutive securities for this calculation consist of warrants to purchase common stock that are either liability classified or equity classified, stock options, unvested restricted stock and unvested restricted stock units (see Note 15 - Equity Incentive Plan and Note 16 - Warrants for further detail). If the Company’s adjusted numerator for net income from continuing operations divided by the diluted weighted-average number of common shares outstanding for each potentially dilutive security was greater than the net income from continuing operations per share, then the Company did not include those common equivalent shares in the computation of diluted net income or loss from continuing operations per share; diluted net income or loss from discontinued operations, net of tax; or diluted net income or loss per share because the effect would have been anti-dilutive.

 

The following is a reconciliation of the numerator and the denominator used in the basic per share calculations:

 

  

Three Months Ended

 
  

September 30,

 
  

2025

  

2024

 
  

(in thousands, except share and per share data)

 

BASIC

        

Numerators:

        

Net income from continuing operations

 $1,965  $1,093 

Net income from discontinued operations, net of tax

     381 

Net income

 $1,965  $1,474 

Denominator:

        

Basic weighted-average common shares outstanding

  9,441,073   6,068,019 

Basic per share calculations:

        

Net income per share from continuing operations

 $0.21  $0.18 

Net income per share from discontinued operations, net of tax

 $  $0.06 

Net income per share

 $0.21  $0.24 

 

The following is a reconciliation of the numerator and the denominator used in the diluted per share calculations:

 

  

Three Months Ended

 
  

September 30,

 
  

2025

  

2024

 
  

(in thousands, except share and per share data)

 

DILUTED

        

Numerators:

        

Adjusted numerator - net loss from continuing operations (1)

 $(1,505) $(1,787)

Net income from discontinued operations, net of tax

     381 

Net loss

 $(1,505) $(1,406)

Denominator:

        

Basic weighted-average common shares outstanding

  9,441,073   6,068,019 

Dilutive effect of warrants to purchase common stock

  10,035,562   3,028,862 

Dilutive effect of options to purchase common stock

     2,720 

Diluted weighted-average common shares outstanding

  19,476,635   9,099,601 

Diluted per share calculations:

        

Net loss per share from continuing operations

 $(0.08) $(0.20)

Net income per share from discontinued operations, net of tax

 $  $0.04 

Net loss per share

 $(0.08) $(0.15)

(1) 

The net income from continuing operations numerator has been adjusted to remove the changes in fair value of certain warrant liabilities totaling a gain of $3.5 million and $2.9 million for the three months ended September 30, 2025, and 2024, respectively.

 

The following table sets forth securities that could be considered anti-dilutive, and therefore are excluded from the calculation of diluted weighted-average common shares outstanding and related per share calculations:

 

  

Three Months Ended

 
  

September 30,

 
  

2025

  

2024

 

Warrants to purchase common stock - liability classified (note 16)

  3,144,536   455,392 

Warrants to purchase common stock - equity classified (note 16)

  15,571   18,114 

Weighted-average of warrants exercised to common stock (note 16)

  495,000    

Outstanding stock options (note 15)

  206,800   10,644 

Unvested restricted stock (note 15)

  31,298   1,211 

Unvested restricted stock units (note 15)

     141,439 

Total anti-dilutive securities

  3,893,205   626,800